ATOSSA THERAPEUTICS, INC. (ATOS) › Net IncomeATOSSA THERAPEUTICS, INC. (ATOS) — Net IncomeAnnual figures by fiscal year, from SEC filings.2010: -$1.09M2011: -$3.44M2012: -$5.08M2013: -$10.78M2014: -$14.66M2015: -$15.76M2016: -$6.37M2017: -$8.12M2018: -$11.40M2019: -$17.24M2020: -$17.83M2021: -$20.61M2022: -$26.96M2023: -$30.09M2024: -$25.50M2025: -$34.77M-$34.77M2010Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$34.77M-36.3%2024-$25.50M+15.3%2023-$30.09M-11.6%2022-$26.96M-30.8%2021-$20.61M-15.6%2020-$17.83M-3.4%2019-$17.24M-51.2%2018-$11.40M-40.4%2017-$8.12M-27.5%2016-$6.37M+59.6%2015-$15.76M-7.5%2014-$14.66M-35.9%2013-$10.78M-112.3%2012-$5.08M-47.6%2011-$3.44M-216.7%2010-$1.09M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share